ethylisopropylamiloride has been researched along with Arteriosclerosis in 1 studies
ethylisopropylamiloride: structure in first source
ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group.
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YX | 1 |
| Ma, X | 1 |
| Whitman, S | 1 |
| O'brien, ER | 1 |
1 other study available for ethylisopropylamiloride and Arteriosclerosis
| Article | Year |
|---|---|
Novel antiinflammatory vascular benefits of systemic and stent-based delivery of ethylisopropylamiloride.
Topics: Amiloride; Animals; Anti-Inflammatory Agents; Aorta; Apolipoproteins E; Arteriosclerosis; Cell Adhes | 2004 |